The state of Alabama currently has 14 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
10/17/2024
Locations: The University of Alabama at Birmingham, Birmingham, Alabama +1 locations
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Recruiting
The purpose of the study is to see if imaging with fluorine-18 Fluorodeoxyglucose (\[18F\] FDG) and fluorine-18 Displacement Per Atom (\[18F\]DPA-714) using positron emission tomography and computed tomography (PET/CT) will show lung inflammation and fibrosis in patients diagnosed with idiopathic pulmonary fibrosis (IPF). This study may help physicians and researchers better understand how best to treat patients with IPF in the future.
Gender:
ALL
Ages:
Between 40 years and 85 years
Trial Updated:
10/08/2024
Locations: The University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Idiopathic Pulmonary Fibrosis